CXCR4 in Waldenström's Macroglobulinemia: chances and challenges
Buske C, et al.
Leukemia · 2021
Grade Bnarrative review
Key Findings
- ●CXCR4 mutations affect up to 40% of WM patients with >40 different mutations described
- ●Mutations similar to germline WHIM syndrome mutations
- ●CXCR4 mutations lead to more aggressive clinical course and inferior BTK inhibitor response
Referenced in (1 disease)
ID: pmid-33273682DOI: 10.1038/s41375-020-01102-3PMID: 33273682